Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Severe Acute Respiratory Syndrome 1Pneumonia 1Lymphoma, Follicular 1COVID-19 1

Interventions

Methylprednisolone 2Etanercept 2Bronchoalveolar Lavage 2ziprasidone 1Zolpidem 1XAV-19 1X-Rays 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Ultrasonography 1Tranexamic Acid 1Tobramycin 1Surveys and Questionnaires 1Spironolactone 1Sodium Bicarbonate 1Sevelamer 1Saline Solution 1Rocuronium 1Ribavirin 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Mass Screening 1Lurasidone Hydrochloride 1Labetalol 1Haloperidol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pneumonia × XAV-19 × Clear all
NCT04453384 2022-03-25

POLYCOR

Nantes University Hospital

Phase 2 Completed
416 enrolled
Lymphoid

COVID-19, Lymphoma, Follicular, Pneumonia, Severe Acute Respiratory Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡